New York

Antitrust in Life Sciences

"Antitrust in Life Sciences - 3rd Annual Edition” Conference organised by Concurrences, in partnership with Bates White, Cornerstone Research, Dechert, Gibson Dunn, and Morrison & Foerster.

KEYWORDS

– Video: Available for Concurrences+ subscribers (see below)
– Photos: See below
– Audio: Available for Concurrences+ subscribers (see above)
– Synthesis: Available for Concurrences+ subscribers (see above)
– Transcript: Available for Concurrences+ subscribers (see above)
– Concurrences Related Articles (Click Read More below and see page’s bottom)

Check the Upcoming Conferences section for the next events.

SYNTHESIS

Panel 1 - Mergers in the Health Sector

Thomas DeMatteo

This panel will focus on the significant increase in hospital merger activity over the past decade, the issues relating to pharmaceuticals but also of the impact of new developments.

Martin Gaynor

In every country, healthcare is a very important sector. In the US, one dollar out of every five is spent on healthcare. The money that is spent in this sector has an impact on health, productivity, and quality of life. The US relies on markets for the provision and financing of healthcare. Therefore, the healthcare system can only work if the markets support it. Currently, the markets do not work as well as they should. Indeed, prices are high and are rising, there is too little organizational innovation. It is a stagnant sector.

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.